Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208091 · ClinicalTrials.gov registry record · Phase 4
Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia
A Phase 4 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT00208091 is a Phase 4 study that has completed, run by Columbia University. The registered enrollment target is 16 participants.
The verdict
NCT00208091, a Phase 4 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study uses a computerized method of musical instrument digital interface (MIDI) quantification of performance before and after treatment with botulinum toxin type B (Myobloc ®, Solstice Neurosciences). Myobloc is a purified and diluted form of botulinum toxin used medically to relax unwanted muscle spasms and movements. The aim of the study is to determine the feasibility of quantifying change in performance following treatment.
Interventions
- DRUG Botulinum toxin, type B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2003-04 |
| Est. Completion | 2008-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208091
The ClinicalTrials.gov registry entry for NCT00208091 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Botulinum toxin, type B is the first listed.
NCT00208091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00208091 about?
NCT00208091 is a clinical study titled "Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia". This study uses a computerized method of musical instrument digital interface (MIDI) quantification of performance before and after treatment with botulinum toxin type B (Myobloc ®, Solstice Neurosciences). Myobloc is a purified and diluted form of botulinum toxin used medically to relax unwanted mu...
What is the current status of trial NCT00208091?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2003-04. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00208091?
The interventions under investigation include: Botulinum toxin, type B (DRUG).
Who is sponsoring clinical trial NCT00208091?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.